Yuki Ishikawa

1.6k citations
38 papers · 1.0k indexed · h-index 15

Yuki Ishikawa

36 papers receiving 1.0k citations

Peers

Yuki Ishikawa
Comparison fields: 5 of 93
  • Radiology, Nuclear Medicine and Imaging 387
  • Rheumatology 194
  • Public Health, Environmental and Occupational Health 220
  • Immunology 122
  • Genetics 61
Replace Sun Young Jang with:
Sun Young Jang South Korea
Hajime Horiuchi Japan
Fehim Esen Türkiye
Hiroshi Tsujioka Japan
A C McCartney United Kingdom
PP Tak Netherlands
Naoyuki Yamakawa Japan
Andrew Chantry United Kingdom
George E. Sanborn United States
Paola Pérez United States
Yuki Ishikawa relative to Sun Young Jang South Korea Sun Young Jang's profile →
Citations per field
00.5×4.8×
Sun Young Jang · 1×
Citations per year

Countries citing papers authored by Yuki Ishikawa

Since Specialization
Citations

This map shows the geographic impact of Yuki Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Ishikawa more than expected).

Fields of papers citing papers by Yuki Ishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Ishikawa. The network helps show where Yuki Ishikawa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yuki Ishikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuki Ishikawa Line = papers co-authored together Yuki Ishikawa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20260
2 20251
3 20245
4 20243
5 20233
6 20221
7 202251
8 202125
9 202074
10 201941
11 20191
12 201910
13 201812
14 201831
15 201791
16 201610
17 201432
18 2012114
19 201131
20 201049

About Yuki Ishikawa

Yuki Ishikawa is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 38 papers that have together received 1.0k indexed citations. Recurring topics across this work include Corneal Surgery and Treatments (9 papers), Systemic Lupus Erythematosus Research (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Pluripotent Stem Cells Research (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Retinal Development and Disorders (4 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (387 citations), Rheumatology (194 citations) and Public Health, Environmental and Occupational Health (220 citations). Yuki Ishikawa has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Chikashi Terao, Kohji Nishida, Ryuhei Hayashi, Andrew J. Quantock, Motokazu Tsujikawa, Tsuneyo Mimori, Kiyotoshi Sekiguchi, Yuzuru Sasamoto, Takashi Usui and Naoki Nomura. Their work appears in journals such as Nature, Journal of Biological Chemistry and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026